Private-equity firm Thoma Bravo taking company public at an estimated market cap of $11 billion in its return to the stock ...
McKesson acquires 80% of PRISM Vision Holdings for $850M, expanding their presence in ophthalmology and retina management services.
The Goodyear Tire & Rubber Company (NASDAQ: GT) ("Goodyear" or the "Company") has completed the previously announced divestiture ...
Metsera, a clinical-stage biotechnology firm, debuted on the Nasdaq Global Select Market today. After initially offering its ...
Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.
Metsera, Inc. (Nasdaq: MTSR) ("Metsera"), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone ...
A registration statement on Form S-1 (File No. 333-284225) relating to the offering has been filed with the Securities and Exchange Commission and became effective on January 30, 2025. The offering is ...
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...
Juniper Networks' standalone value at $31.50/share as DOJ blocks sale to HPE. Analyst sees limited downside, shares slide 2%.